On June 18, 2022, the Centers for Disease Control and Prevention (CDC) gave final approval for kids 6 months and older to be vaccinated against
Children’s Minnesota offers three therapies for treating or preventing COVID-19 in kids: Paxlovid, Bebtelovimab and Evusheld. These therapies are authorized by the U.S. Food and
Watch the upcoming Grand Rounds about Asian American communities in Minnesota and COVID-19.
Join the upcoming Grand Rounds about Asian American communities in Minnesota and COVID-19.
. “How Children’s hospitals can plan for the future of pediatric care and COVID-19” explored what children’s hospitals have learned since the pandemic began in
Over the past two years, the COVID-19 pandemic created a surge in multi-system inflammation syndrome in children (MIS-C).
Children’s Minnesota is honored to announce that renowned medical ethicist Harriet A. Washington was the guest speaker for our Grand Rounds that focused on the
Two years since the start of the COVID-19 pandemic, executives from the largest health care organizations in the Twin Cities came together to talk about
A new study from the Centers for Disease Control and Prevention (CDC) confirmed the effectiveness of the Pfizer-BioNTech (mRNA) COVID-19 vaccine to protect non-immunocompromised kids
Reach us 24/7 for patient referrals, consults, admissions and neonatal transport.
© 2024 Children’s Minnesota
Children’s Minnesota is registered as a 501(c)(3) non-profit organization. Our tax identification number is 41-1754276.
